Dr. Malik serves as the CEO of SK pharmteco, a U.S.-based CDMO with global headquarters in Sacramento, CA and operations in Korea, Ireland and the United States. Pharmteco is the recent combination of SK biotek Korea, SK biotek Ireland and AMPAC Fine Chemicals. Prior to the establishment of SK pharmteco, Dr. Malik served as the President and CEO of AMPAC Fine Chemicals. Dr. Malik holds a doctorate degree in organic chemistry from the University of California at San Diego, a Master’s degree in organic chemistry from San Diego State University and a Bachelor’s degree in chemistry and physics from St. Xavier’s College in India.